Gabelli Healthcare & WellnessRx Trust's gross profit is $18M, below the sector sector average of $790M.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2025
Trailing 12 months ending Dec 31, 2025
The latest gross profit for GRX is $18M as of December 2025. That compares with $25M in the prior-year period — down 29.5% year over year. That is below the sector sector average of $790M. Investors often review this figure alongside Gabelli Healthcare & WellnessRx Trust's historical trend and sector peers before judging valuation or financial health.
Over the past year, GRX's gross profit moved from $25M to $18M — a 29.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Gabelli Healthcare & WellnessRx Trust's operating scale or balance-sheet position.
Against its sector companies, GRX currently prints $18M for gross profit, while the sector average sits near $790M. That is roughly 97.8% below the sector mean. Large gaps often invite a closer look at Gabelli Healthcare & WellnessRx Trust's growth, margins, and balance sheet.
A gross profit figure of $18M for GRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $790M. Explore the charts below for those layers of context.
After noting GRX's gross profit ($18M), review year-over-year change from $25M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.